
Areas of Expertise
Conditions I Treat
- Lung cancer
My Specialties
- Immunotherapy
- Clinical trials
Get to Know Me
I am a medical oncologist specializing in the treatment of lung cancer. In concert with a team of experts across medical specialties, like surgery and radiation oncology, I work with patients to create treatment plans tailored not only to the specific needs of their disease, but also to their goals and preferences for care.
When patients meet with me, I want them to feel heard and reassured that I will be there to support them each step the way. My MSK colleagues and I are attuned to the diverse ways in which a cancer diagnosis can impact a person’s life. Partnering with our patients to identify the treatment path that is right for them is our mission.
Read more
To that end, we are always hoping to improve upon the treatment options currently available for lung cancer. I have held a long-standing interest in improving patient outcomes through clinical research, with an emphasis on biomarkers as indicators of treatment response and resistance. At Memorial Sloan Kettering Cancer Center, I lead clinical trials of novel therapeutics and combination treatment strategies. I collaborate with MSK’s laboratory-based researchers to investigate how and why new treatment regimens work in lung cancer. Ultimately, my goal as a clinician and researcher is to advance knowledge in the field of lung cancer for the benefit of current and future patients.
A thoracic medical oncologist is a cancer doctor who specializes in thoracic (thor-A-sik) cancers. These are cancers that have to do with the chest, including lung, tracheal (windpipe), and thymic (thymus) cancers.
- Assistant Attending Physician
Conditions I Treat
- Lung cancer
My Specialties
- Immunotherapy
- Clinical trials
Education
- MD, Warren Alpert Medical School of Brown University
Residencies
- Internal Medicine, Brigham and Women's Hospital, Harvard Medical School
Fellowships
- Hematology/Oncology, Dana-Farber Cancer Institute/Mass General Brigham, Harvard Medical School
Awards and Honors
- Targeted Therapies of Lung Cancer Education Award, International Association for the Study of Lung Cancer, (2022, 2023)
- Chief Fellow, Medical Oncology, Dana-Farber Cancer Institute/Mass General Brigham Fellowship Program (2022-2023)
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
HMO
City Employee Health Plans (Gold and Gold Care)
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment

Contact and Location
Dr. Cooper sees patients at two locations.






Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Cooper
- A Phase 1 Study of ABBV-706 in People With Solid Tumors
- A Phase 1 Study of Valemetostat Tosylate in Combination With Dato-DXd in People With Lung Cancer and With T-DXd in People With Digestive Cancers
- A Phase 1/2 Study of MRT-2359 in People with Advanced Lung Cancer and Other Solid Tumors
- A Phase I/II Study of HPN328 Immunotherapy in People with Cancer That Makes the DLL3 Protein
Read more
- Clinical Trials Co-Investigated by Dr. Cooper
- A Phase 1 Study of LY4170156 in People With Solid Tumors
- A Phase 1 Study of Valemetostat Plus Atezolizumab in People With Small Cell Lung Cancer
- A Phase 1/2 Study of Iadademstat With Other Immunotherapy Drugs for Extensive-Stage Small Cell Lung Cancer
- A Phase 1b/2 Study of Ifinatamab Deruxtecan Plus Atezolizumab With or Without Carboplatin in People With Advanced Small Cell Lung Cancer
- A Phase I Study of STK-012 Alone and with Pembrolizumab Immunotherapy in People with Solid Tumors

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Cooper’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
4.9 157 reviews
- 4.9 Provider's Explanations Easy to Understand
- 4.8 Trusts Provider with Care
- 4.9 Provider Listened Carefully
- 4.9 Likelihood of Recommending Provider
Dr. Cooper was terrific!
Always an Excellent experience because MSK simply CARES.
Many thanks to Alissa Cooper, MD for her attention and information about available clinical trials. Best regards, [patient name removed]'s family
Dr. Cooper is wonderful... just wonderful... thank you!
My family could not be happier with our first appointment. Everyone was so kind and helpful. The RN and Dr. Cooper were thorough and helped to put us at ease. Dr. Cooper explained everything and answered our questions. We are so thankful we got into MSK and look forward to seeing Dr. Cooper again soon.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Alissa J. Cooper discloses the following relationships and financial interests:
-
Gilead Sciences, Inc.
Professional Services and Activities
-
MJH Life Sciences
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.